ArticleDiscover oncology2025
Clinicopathological patterns and treatment outcomes of pediatric germ cell tumors treated at Tikur Anbessa Specialized Hospital, Ethiopia: a single tertiary hospital experience.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPediatric germ cell tumors (GCTs) are rare, heterogeneous neoplasms with peak incidence in children under 4 years of age and during adolescence. The clinical presentation and treatment outcomes of GCTs are not well-studied in developing countries. This study aimed to assess the clinicopathological patterns and treatment outcomes of pediatric GCT patients treated at the largest tertiary referral hospital in Ethiopia.
methodsA retrospective cross-sectional study was conducted at Tikur Anbessa Specialized Hospital, Ethiopia, on pediatric GCT patients treated between January 1, 2013, and December 31, 2023. Data were collected and analyzed using SPSS version 25. The Kaplan-Meier survival estimate was employed to evaluate Overall Survival (OS) and Event-Free Survival (EFS). The log-rank test was used to compare Kaplan-Meier curves, P < 0.05 was considered to indicate a statistically significance.
resultsA total of 91 patients were included in the study. The median age at diagnosis was 4 years, with a predominance of females. Children under 5 years of age constituted 61.6% (n = 56) of the cases. Sacrococcygeal swelling was the most common presenting symptom, accounting for 38.2% (n = 34), followed by abdominal mass accounted for 36%. Most patients (93.4%, n = 85) had extra-cranial GCTs, with mature teratoma being the most prevalent histological subtype (52.6%). Approximately 42.5% of patients received a combination of chemotherapy and local control measures, primarily surgery. Kaplan-Meier survival analysis revealed that the 1-year and 5-year OS rates were 92.7% and 85%, respectively, while the 1-year and 5-year EFS rates were 95% and 84%, respectively.
conclusionThis study demonstrated that the median age at diagnosis for pediatric GCTs was 4 years, with a female predominance. Mature teratoma was the most frequent histological subtype. The observed 1-year and 5-year OS rates were comparable to other studies conducted in similar setting in low- and middle-income countries.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.